These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 58054)

  • 21. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography.
    Irons LI; MacLennan AP
    Biochim Biophys Acta; 1979 Sep; 580(1):175-85. PubMed ID: 232665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures.
    Morse SI; Bray KK
    J Exp Med; 1969 Mar; 129(3):523-50. PubMed ID: 4304138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leucocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization.
    Sato Y; Arai H
    Infect Immun; 1972 Dec; 6(6):899-904. PubMed ID: 4344632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis].
    Semina IE; Iankina ZK
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Properties of an acellular preparation of Bordetella pertussis and its analysis after centrifugation in saccharose gradient].
    Letowska I; Kaczurba E; Schiller B
    Med Dosw Mikrobiol; 1993; 45(3):289-94. PubMed ID: 8189799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STUDIES ON THE LYMPHOCYTOSIS INDUCED IN MICE BY BORDETELLA PERTUSSIS.
    MORSE SI
    J Exp Med; 1965 Jan; 121(1):49-68. PubMed ID: 14253487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocytosis and histamine sensitization of mice by fractions from Bordetella pertussis.
    Clausen C; Munoz J; Bergman RK
    J Bacteriol; 1968 Nov; 96(5):1484-7. PubMed ID: 4302297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings: Hemagglutinating substance of Bordetella pertussis.
    Nakase Y; Doi M; Kasuga T
    Jpn J Med Sci Biol; 1975 Feb; 28(1):57-9. PubMed ID: 169414
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.
    Meade BD; Kind PD; Ewell JB; McGrath PP; Manclark CR
    Infect Immun; 1984 Sep; 45(3):718-25. PubMed ID: 6088394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels.
    Askelöf P; Gillenius P
    Infect Immun; 1982 Jun; 36(3):958-61. PubMed ID: 6284647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.
    Morse JH; Kong AS; Lindenbaum J; Morse SI
    J Clin Invest; 1977 Sep; 60(3):683-92. PubMed ID: 197121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Bordetella pertussis lymphocytosis-promoting factor (LPF) on antibody response in mice: its enhancing and suppressive effects.
    Asakawa S; Iwasa S
    Jpn J Med Sci Biol; 1982 Feb; 35(1):25-9. PubMed ID: 6285047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells.
    Kashiwa H; Hyodo S; Kishi T; Karakawa T; Kittaka E; Suzawa T; Sakano T; Usui T
    Clin Exp Immunol; 1984 Nov; 58(2):436-43. PubMed ID: 6094059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of heat-labile toxin of B. pertussis on mouse blood cells: the determination of LPF (leukocytosis-promoting factor)].
    Ishida S; Kurokawa M
    Igaku To Seibutsugaku; 1972 Apr; 84(4):255-9. PubMed ID: 4340315
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant for IgE antibody and islet-activating protein in Bordetella pertussis.
    Mizushima Y; Mori M; Ogita T; Nakamura T
    Int Arch Allergy Appl Immunol; 1979; 58(4):426-9. PubMed ID: 220196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. II. The effect of pertussis vaccine on the thoracic duct lymph and lymphocytes of mice.
    Morse SI; Riester SK
    J Exp Med; 1967 Apr; 125(4):619-28. PubMed ID: 4289740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.